Sclerostin-targeted delivery of PCSK9 siRNA reverses osteoporosis in OVX mice

Key Points

• Reversal of osteoporosis observed following targeted delivery of PCSK9 siRNA.
• Ovariectomized (OVX) mice showed significant improvements in bone density metrics.
• Targeted delivery approach enhances siRNA efficacy in disrupting sclerostin pathways.
• This research highlights the potential of targeting specific molecular pathways for therapeutic interventions.